InsiderGauge
Checking updates…
Dashboard

Welgus Howard G.insider trades

In SEC Form 4 filings, Welgus Howard G. is listed as Director of Arcutis Biotherapeutics, Inc. (ARQT). In the last 90 days, Welgus Howard G. sold $241.7K of Arcutis Biotherapeutics, Inc. (ARQT) on the open market and bought none. All 2 sales were reported under a 10b5-1 trading plan.

Companies and roles

CompanyRoleTransactionsLast filed
ARQTArcutis Biotherapeutics, Inc.Director14Oct 19

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-17

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
ARQTArcutis Biotherapeutics, Inc.Oct 15Oct 19M822$6.52$5,36136,663YesForm 4
ARQTArcutis Biotherapeutics, Inc.Oct 15Oct 19M1,018$7.51$7,64537,681YesForm 4
ARQTArcutis Biotherapeutics, Inc.Oct 15Oct 19M2,254$8.63$19,45239,935YesForm 4
ARQTArcutis Biotherapeutics, Inc.Oct 15Oct 19S4,728$26.93Sale −$127,32535,207YesForm 4
ARQTArcutis Biotherapeutics, Inc.Oct 15Oct 19M · derivative822$6.52$5,3615,752YesForm 4
ARQTArcutis Biotherapeutics, Inc.Oct 15Oct 19M · derivative1,018$7.51$7,6457,126YesForm 4
ARQTArcutis Biotherapeutics, Inc.Oct 15Oct 19M · derivative2,254$8.63$19,45215,778YesForm 4
ARQTArcutis Biotherapeutics, Inc.Sep 15Sep 17M822$6.52$5,36137,297YesForm 4
ARQTArcutis Biotherapeutics, Inc.Sep 15Sep 17M1,019$7.51$7,65338,316YesForm 4
ARQTArcutis Biotherapeutics, Inc.Sep 15Sep 17M2,255$8.63$19,46140,571YesForm 4
ARQTArcutis Biotherapeutics, Inc.Sep 15Sep 17S4,730$24.18Sale −$114,37135,841YesForm 4
ARQTArcutis Biotherapeutics, Inc.Sep 15Sep 17M · derivative822$6.52$5,3616,574YesForm 4
ARQTArcutis Biotherapeutics, Inc.Sep 15Sep 17M · derivative1,019$7.51$7,6538,144YesForm 4
ARQTArcutis Biotherapeutics, Inc.Sep 15Sep 17M · derivative2,255$8.63$19,46118,032YesForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.